Hyperinsulinemia：治療薬のグローバル治験動向（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hyperinsulinemia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Hyperinsulinemia to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Hyperinsulinemia to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Hyperinsulinemia Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Torrent Pharmaceuticals Limited 26
Clinical Trial Overview of Torrent Pharmaceuticals Limited 26
GlaxoSmithKline plc 27
Clinical Trial Overview of GlaxoSmithKline plc 27
Clinical Trial Overview of Top Institutes / Government 28
National Heart, Lung, and Blood Institute 28
Clinical Trial Overview of National Heart, Lung, and Blood Institute 28
Assistance Publique – Hopitaux de Paris 29
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 29
The Sheba Medical Center 30
Clinical Trial Overview of The Sheba Medical Center 30
The Children’s Hospital of Philadelphia 31
Clinical Trial Overview of The Children’s Hospital of Philadelphia 31
Aarhus University 32
Clinical Trial Overview of Aarhus University 32
FDA Office of Orphan Products Development 33
Clinical Trial Overview of FDA Office of Orphan Products Development 33
National Center for Research Resources 34
Clinical Trial Overview of National Center for Research Resources 34
Rijnstate Hospital 35
Clinical Trial Overview of Rijnstate Hospital 35
Yale University 36
Clinical Trial Overview of Yale University 36
Kyoto University 37
Clinical Trial Overview of Kyoto University 37
Five Key Clinical Profiles 38
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 72